Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Scleroproteins – e.g. – fibroin – elastin – silk – etc.
Patent
1986-03-26
1987-10-27
Kight, John
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Scleroproteins, e.g., fibroin, elastin, silk, etc.
128DIG8, 424485, 424 9464, 514801, 523105, 523111, A23J 110, C08H 106
Patent
active
047031085
ABSTRACT:
There are disclosed processes for preparing biodegradable collagen-based matrices in sponge or sheet form wherein in one embodiment a collagen-based material including a collagen selected from the group consisting of types I, II and II collagens is freeze dried to form a collagen-based sponge which is contacted with a cross-linking agent selected from the group consisting of a carbodiimide or a succinimidyl active ester to form an intermediate collagen-based matrix which is subsequently subjected to conditions of severe dehydration to form the collagen-based matrix in sponge or sheet form. In another embodiment, a collagen-based sponge or sheet is first subjected to conditions of severe dehydration followed by contacting the thus formed intermediate collagen-based matrix with a carbodiimide crosslinking compound to form the collagen-based matrix in sponge or sheet form. In still another embodiment of the present invention the cross-linking agent is admixed with the collagen-based material prior to formation of the collagen-based sponge or sheet followed by processing steps of severe dehydration. In a particularly preferred form of the invention, a carrier compound is incorporated during processing to form a collagen-based matrix in sponge or sheet form impregnated with a carrier compound wherein the carrier compound is selected from the group consisting of types IV and V collagen, fibronectin, laminin, hyaluronate, proteoglycan, epidermal growth factor, platelet derived growth factor, angiogenesis factor, antibiotic, antifungal agent, spermacidal agent, enzyme and enzyme inhibitor.
REFERENCES:
patent: 3098693 (1963-07-01), Sheehan
patent: 3300470 (1967-01-01), Young
patent: 3800792 (1974-04-01), McKnight
patent: 3903882 (1975-09-01), Augurt
patent: 3955012 (1976-05-01), Okamura
patent: 4060081 (1977-11-01), Yannas et al.
patent: 4280954 (1981-07-01), Yannas
patent: 4350629 (1982-09-01), Yannas
patent: 4352883 (1982-10-01), Lim
patent: 4363758 (1982-12-01), Masuho et al.
patent: 4374121 (1983-02-01), Cioca
patent: 4399123 (1983-08-01), Oliver
patent: 4409332 (1983-10-01), Jefferies et al.
patent: 4412947 (1983-11-01), Cioca
patent: 4418691 (1983-12-01), Yannas
patent: 4458678 (1984-07-01), Yannas
Doillen et al., Scanning Election Micropscopy 1985, pp. 897-903.
Silver et al., J. Biomedical Materials Research, vol. 13, 701-715 (1979).
Silver et al., Thrombosis Research, vol. 13, pp. 267-277 (1978).
Weadock et al., Biomat, Med.Dev., Art.Org., 11(4),293-318 (1983-84).
Chem. Abstracts 82:744856, 1975, Ruben et al., J. Clinical Pharmacology, pp. 309-312 (1973).
Chemical and Engineering News, Oct. 4, 1965.
Berg Richard A.
Birk David E.
Silver Frederick A.
Weadock Kevin
Whyne Conrad
Kight John
Nutter Nathan M.
University of Medicine & Dentistry of New Jersey
LandOfFree
Biodegradable matrix and methods for producing same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biodegradable matrix and methods for producing same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biodegradable matrix and methods for producing same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1273028